HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact ...
SAN FRANCISCO, CA / ACCESSWIRE / January 27, 2023 / Hagens Berman urges Fate Therapeutics, Inc. FATE investors who suffered significant losses to submit your losses now. Class Period: Apr. 2, 2020 - Jan. 5, 2023 Lead Plaintiff Deadline: Mar. 22, 2023 Visit …